Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Alisha Bellezza Biography and Net Worth

Insider of Chemours

Alisha Bellezza has over two decades of finance and chemical industry experience and leads Chemours’ Thermal & Specialized Solutions business (formerly fluorochemicals).

Alisha joined Chemours in 2015, where she helped to establish and led the investor relations function at spin. Within a year, she also took on the role of vice president and treasurer during which she led the company's first public debt offering post-spin, helped increase financial flexibility and liquidity, and initiated a share repurchase program.

Always ready to take on new opportunities, in her third year with Chemours Alisha stepped into the vice president, global sales, commercial operations and supply chain for the Titanium Technologies business where she delivered significant business growth in her first six months. She also developed and implemented new go-to-market strategies, including an e-commerce platform, innovative pricing mechanisms and differentiated offerings.

Before joining Chemours, Alisha held positions in investor relations, corporate strategy & development, and finance at FMC Corporation in the Agricultural Products Group and at the corporate level. She began her career as a financial analyst in banking at Bank One Corporation and First Bank & Trust, holding progressive leadership positions before joining Verizon Communications.

Alisha received her Bachelor of Science in economics from Tulane University in New Orleans, Louisiana, and earned her Master of Business Administration from Georgetown University in Washington, D.C.

What is Alisha Bellezza's net worth?: The estimated net worth of Alisha Bellezza is at least $829,856.59 as of March 6th, 2023. Ms. Bellezza owns 43,931 shares of Chemours stock worth more than $829,857 as of November 17th. This net worth estimate does not reflect any other assets that Ms. Bellezza may own. Learn More about Alisha Bellezza's net worth.
How do I contact Alisha Bellezza?: The corporate mailing address for Ms. Bellezza and other Chemours executives is 1007 MARKET STREET, WILMINGTON DE, 19801. Chemours can also be reached via phone at (302) 773-1000 and via email at [email protected]. Learn More on Alisha Bellezza's contact information.
Has Alisha Bellezza been buying or selling shares of Chemours?: Alisha Bellezza has not been actively trading shares of Chemours within the last three months. Most recently, Alisha Bellezza sold 27,716 shares of the business's stock in a transaction on Monday, March 6th. The shares were sold at an average price of $35.47, for a transaction totalling $983,086.52. Following the completion of the sale, the insider now directly owns 43,931 shares of the company's stock, valued at $1,558,232.57. Learn More on Alisha Bellezza's trading history.
Who are Chemours' active insiders?: Chemours' insider roster includes Matthew Abbott (CAO), Alisha Bellezza (Insider), Denise Dignam (President and Chief Executive Officer), Mark Newman (CEO), Sameer Ralhan (CFO), Alvenia Scarborough (SVP), David Shelton (SVP), Edwin Sparks (Insider), and Mark Vergnano (Director). Learn More on Chemours' active insiders.
Are insiders buying or selling shares of Chemours?: In the last twelve months, insiders at the specialty chemicals company sold shares 2 times. They sold a total of 7,573 shares worth more than $156,189.92. The most recent insider tranaction occured on November, 7th when SVP Alvenia Scarborough sold 7,500 shares worth more than $154,800.00. Insiders at Chemours own 0.5% of the company. Learn More about insider trades at Chemours.
Information on this page was last updated on 11/7/2024.

Alisha Bellezza Insider Trading History at Chemours

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/6/2023	Sell	27,716	$35.47	$983,086.52	43,931
5/5/2022	Sell	14,365	$40.48	$581,495.20	38,797

Alisha Bellezza Buying and Selling Activity at Chemours

Chemours Company Overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for electronics, communications, transportation, wire and cable, energy, oil and gas, and medical, and other applications under the eflon, Viton, Krytox, and Nafion brands. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $18.89

$18.77

$19.38

50 Day Range

MA: $19.12

$16.79

$20.80

2 Week Range

Now: $18.89

$15.10

$32.70

Volume

1,889,033 shs

Average Volume

1,769,015 shs

Market Capitalization

$2.82 billion

P/E Ratio

37.78

Dividend Yield

5.29%

Beta

1.75

Has Trump Finally Gone Too Far?

From Insiders Exposed | Ad